Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06163573 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 2 of 9 sitesv13
  2. Eligibility criteria expanded, about 12 words
    • Site contacts updated at 1 of 9 sites
    v12
  3. Re-verified, no change to tracked fieldsv11
  4. Study sites revised (9)v10
  5. Secondary endpoints: 8 to 14v9
Show 7 earlier versionsHide 7 earlier versions
  1. Eligibility criteria expanded, about 388 wordsv8
  2. Site details revised at 1 of 9 sitesv7
  3. Study sites: 10 to 9
    • Study description revised
    v6
  4. Study sites: 9 to 10
    • Study description revised
    v5
  5. Site details revised at 1 of 9 sitesv4
  6. Secondary endpoints reordered
    • Site details revised at 2 of 9 sites
    v3
  7. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2024 to Jun 6, 2024
    • Secondary endpoints: 6 to 8
    • Site details revised at 9 of 9 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this investigator-initiated study is to assess the efficacy of treating patellofemoral osteoarthritis with an Advanced Therapy Medicinal Product (ATMP), autologous nasal chondrocyte tissue engineered cartilage (N-TEC), in comparison with a standard therapy using platelet rich plasma injections. The engineered cartilage graft is obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane.
Trial Details
NCT Number NCT06163573
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: Swiss National Science Foundation, Clinical Trial Unit, University Hospital Basel, Switzerland, Wuerzburg University Hospital
Conditions
(from sponsor)		 Patellofemoral Osteoarthritis
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov